Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
62 Cards in this Set
- Front
- Back
what is HSV-3 |
Varicella |
|
prototype of antiherpetic drug given orally or intravenously |
Acyclovir |
|
antiherpetic agent that has a 5 time higher concentration that acyclovir |
valacyclovir |
|
antiherpetic agent metabolized to penciclovir |
famciclovir |
|
two types of topical antiherpetic agents |
penciclovir Trifluridine |
|
type of antiherpetic agent that inhibits fusion between plasma membrane and HSV envelop. this drug is also available over the counter |
Docosanol |
|
another type of antiherpetic drug not previously mentioned |
Vidarabine |
|
acyclovir is phosphorylated by what enzyme into what |
viral thymidine kinase to acyclovir-monophosphate |
|
what does its active form do |
inhibits viral DNA polymerase acts as a DNA chain terminator |
|
adverse reactions of acyclovir |
CNS and Renal toxicity |
|
how does a virus develops resistance to acyclovir |
Lack of viral thymidine kinase (activator) Changes in the viral DNA polymerase (target enzyme) |
|
what can be given in cases of resistance to acyclovir
|
foscarnet cidofovir trifluridine |
|
acyclovir is used against what |
Herpes Simplex Virus 1 and 2 and VaricellaZoster |
|
what does it NOT cover |
CMV |
|
how does trifluridine work |
it is Converted to active triphosphate form by host cellular enzymes and is Incorporated into DNA, terminating synthesis |
|
why is it only used topically |
it is too toxic for systemic use because it can be incorporated into host DNA after phosphorylation by host enzyme |
|
what antiherpetic agent is used in the treatment of herpes simplex keratitis and Vaccinia virus keratitis |
trifluridine |
|
what is Docosanol used for |
oro-labial herpes (cold sores) |
|
how does it work |
it blocks HSV envelope fusion with the cellular and viral envelope membranes which prevents entry into host cell |
|
what are the 5 Anti-Cytomegalo virus Agents |
Ganciclovir Valganciclovir Cidofovir Foscarnet Fomivirsen |
|
which Anti-Cytomegalovirus Agent is phosphorylated by host cell |
Cidofovir |
|
which Anti-Cytomegalovirus Agent has no need for phosphorylation |
Foscarnet |
|
is activation of Ganciclovir dependent on viral enzymes |
yes |
|
how does Ganciclovir work |
its Triphosphate form inhibits viral DNA polymerase and cause chain termination |
|
what is Ganciclovir used for |
CMV HSV VZV |
|
Drug of choice for CMV retinitis, pneumonia, and esophagitis |
Ganciclovir |
|
adverse reactions to Ganciclovir |
bonemarrow suppression rash crystalizes in urine CNS (rare) |
|
bone marrow suppression leads to what |
leukopenia and thrombocytopenia |
|
how does Foscarnet work |
Acts by directly inhibiting the DNA and RNA polymerases |
|
what else does it inhibit
|
HIV reverse transcriptase |
|
adverse reaction to Foscarnet |
nephrotoxicity Hypocalcemia Hypomagnesemia |
|
what is Foscarnet used for |
Used for Rx. CMV and acyclovir-resistant strains of HSV also covers ganciclovir-resistant |
|
what is Cidofovir used for
|
treatment of CMV retinitis in AIDS patients |
|
does it need a virus enzyme |
NO |
|
common adverse drug reaction |
proximal tubular nephrotoxicity |
|
what is Fomivirsen mechanism of action |
inhibits protein translation and viral replication by binding to mRNA and destroying it |
|
what is it used for and how is it given |
CMV retinitis (given as an intravitreal injection) |
|
side effects of Fomivirsen |
iritis and increased intraocular pressure |
|
what are the types of influenza |
types A, B, and C |
|
which types are the focus of antiviral treatment |
A and B |
|
which type is responsible for global epidemics such as H3N2-swine flu |
type A |
|
which type is responsible for regional outbreaks |
type B |
|
anti-influenza drugs that are neuraminidase inhibitors |
Oseltamivir Zanamivir |
|
where is neuraminidase found |
found on the outer cell membrane of viral particles |
|
how do neuraminidase inhibitors work |
act directly on this enzyme, interfering with its ability to release and spread the infection throughout the body |
|
neuraminidase inhibitors are active against what |
influenza A & B |
|
when should they be used |
within 36 - 48 hours of onset |
|
which type of neuraminidase inhibitors is only available in inhaler form |
Zanamivir |
|
two other types of anti-influenza drugs |
Amantadine Rimantadine |
|
what do they work against |
Influenza A virus |
|
what is their mechanism of action |
BlockM2 proton ion channel of virus and inhibits uncoating of viral RNA within infected host cells |
|
adverse reactions to Amantadine and Rimantadine |
Insomnia,seizures and arrhythmias at high doses |
|
CNS toxicity is seen more with which one |
amantadine |
|
what other side effects do they cause |
atropine- like peripheral effects and livedo reticularis |
|
what is livedo reticularis |
venous swelling due to capillary thrombi |
|
Interferons are useful in treatment of what |
HBV and HCV by increasing virus RNA as expression |
|
type of oral administration for HCV |
Ribavirin- guanosine analog |
|
what is given as a nebulizer in severe RSV infections |
Ribavirin |
|
what is an antibody to A antigen on RSV and is used for prophylaxis in higher risk children |
Palivizumab |
|
what does Ribavirin do |
InhibitsRNA dependent RNA polymerases andcapping of mRNA |
|
adverse reactions to adverse drug reactions |
hemolytic anemia teratogenic |
|
•Pegylatedinterferon alfa-2a and 2-b refers to what hepatitis |
Hepatitis C |